Pain

Having one of the oldest electronic health record systems in the country the state of Indiana has been at the forefront of the field for close to 30 years. Using those records and networks in the state a group from the Regenstrief Institute looked at how patients might want to control who can see their records.

A medication commonly prescribed to relieve the painful symptoms of multiple types of arthritis has been found to be ineffective in treating pain associated with one particular form of the disease.

One of the many difficulties in treating migraine is that many of those suffering from them don't recognize the symptoms or seek treatment. Chronic migraine in particular is underdiagnosed and undertreated. One way to address underdiagnosis is to put an accurate self-administered tool in the hands of migraine sufferers.

Patients are often asked their level of pain on a scale of 0 to 10, but a new study suggests this may not be the most efficient way to distribute the appropriate dosage of drugs.

A number of studies have shown that gabapentin, developed to treat epilepsy, is effective in treating postherpetic neuralgia and painful diabetic neuropathy. Now, a study has revealed that gabapentin may hold promise for treating fibromyalgia as well.

For decades researchers have been trying to identify the source of the correlation between rheumatoid arthritis (RA) and fatigue – a common symptom of the disease. However, the reason it may have remained a mystery for so long could be because there isn't one.

Researchers will evaluate the safety, pharmacodynamic profile, and immunogenicity of pegsiticase for the treatment of painful refractory and tophaceous gout.

More than 70,000 patients participated in a clinical trial designed to determine the hazard risk of developing psoriatic arthritis (PsA) following physical trauma in patients with psoriasis.

For the first time, a direct biophysical link has been identified that connects chronic pain with mental health and substance abuse.

Spicy food may hold more power than just adding a little zest to a meal. Researchers have uncovered a key interaction that is responsible for the sensations of pain and heat.

A study published in JAMA Internal Medicine found a trifecta of analgesics, self-management tools, and cognitive behavioral therapy (CBT) was effective at mitigating veterans' chronic pain.

Minimally invasive intervention is an effective alternative to current regional anesthetic techniques for the management of post-operative thoracotomy pain.

General physical activity is often part of the prescription for pain patients. But a new secondary analysis published in The European Journal of Pain shows that for patients with whiplash-associated disorders, neck-specific exercises can be effective and well-tolerated as well.

Although commercial support for continuing medical education has been on the decline since 2008, it nevertheless continues to be a major revenue source for CME providers and a cause for potential concern.

Last month's Pain Perspectives focused on the benefits of psychotherapy in depressed patients with chronic pain. However, quality psychotherapy is not always available, and not all patients are open to it. This month, I will be looking at rational pharmacotherapy for the primary care physician in treating the depression that is generally an aspect of chronic pain syndromes.

Pain levels due to diabetic peripheral neuropathy (DPN) may be altered depending on patients' vitamin D levels, a British study. The findings will be presented in a poster session on June 8 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.

In addition to causing potential damage to the joints, cartilage, ligaments, and bones, osteoarthritis (OA) can lead to sleep disturbances that in turn affect a patient's quality of life.

While assessing treatment options for patients with post-traumatic brain injuries, a collaborative team of researchers discovered that oxygen chamber treatment may also benefit patients with fibromyalgia.

While most cases of shingles typically clear up in a matter of a few weeks, the condition has the ability to cause long-term problems.

Low back pain and symptoms of depression are linked, according to a study conducted with twins in Spain.

Despite the fact that the Lyme disease-causing bacterium Borrelia burgdorferi does not show antibiotic resistance, the illness continues to prove to be difficult to fight in the late stages.

When a child's pain is more than just a "boo-boo," determining the severity of the pain and a course of action can be extremely challenging.

Patients with venous thromboembolism (VTE) may require a break from warfarin sodium therapy in order to undergo surgery or other procedures, however, a new study addressed if doing so presents too high of a risk.

Researchers have demonstrate the efficacy of an implantable organic electronic delivery device for the treatment of neuropathic pain in an animal model. The small organic electronic ion pump could be an effective option for patients suffering from severe nerve pain.

Patients with gout may find relief from severe inflammatory pain due to recently explored peripheral system channels.

Chronic painful conditions can have a significant negative impact on a patient's quality of life, but are some conditions worse than others? A recent study sought to determine which chronic pain condition creates the biggest burden on patient quality of life.

The saying "it's all in your head" may not be that far off when it comes to pain, according to a new study measuring brain activity.

Prosthetic joint infection (PJI) occurs after approximately 2% of primary hip or knee replacements and in up to 6% of revisions surgeries, and cost more than $50,000 per episode. A recent review found that many surgeons have altered their approaches to PJI management based on recent clinical findings.

Young leukemia patients are at risk for peripheral neuropathy due to an inherited gene variation, according to research published in JAMA.

The signs and symptoms of rheumatoid arthritis were improved at 3 months after various doses of the JAK 3 inhibitor decernotinib were administered.